论文部分内容阅读
目的观察炎琥宁治疗上呼吸道感染的临床疗效及不良反应。方法将急性上呼吸道感染患者210例随机分为2组各105例,在基础治疗的基础上,观察组给予炎琥宁注射液治疗,对照组给予利巴韦林治疗。比较2组治疗效果及症状体征消失时间。结果观察组总有效率为93.33%明显高于观察组的73.33%,差异有统计学意义(χ2=15.12,P<0.01)。观察组症状和体征消失时间均短于对照组,差异有统计学意义(P<0.01)。结论炎琥宁治疗急性上呼吸道感染疗效显著,值得临床推广应用。
Objective To observe the clinical efficacy and adverse reactions of Yanhuning in the treatment of upper respiratory tract infection. Methods 210 patients with acute upper respiratory tract infection were randomly divided into two groups of 105 cases. On the basis of basic treatment, the observation group was treated with Yanhuning injection and the control group with ribavirin treatment. The effect of treatment and the disappearance of symptoms and signs were compared between the two groups. Results The total effective rate of the observation group was 93.33%, which was significantly higher than that of the observation group (73.33%), the difference was statistically significant (χ2 = 15.12, P <0.01). The symptoms and signs disappeared in the observation group were shorter than the control group, the difference was statistically significant (P <0.01). Conclusion Yan Hu Ning effective treatment of acute upper respiratory tract infection is worthy of clinical application.